Pathogenic conversion of Foxp3 + T cells into TH17 cells in autoimmune arthritis

Nature Medicine

Volumn 20, Issue 1, 2014, Pages 62-68

  Komatsu, Noriko ^a,b   Okamoto, Kazuo ^a,b   Sawa, Shinichiro ^a,b   Nakashima, Tomoki ^b,c   Oh Hora, Masatsugu ^b,c   Kodama, Tatsuhiko ^d   Tanaka, Sakae ^e   Bluestone, Jeffrey A ^f   Takayanagi, Hiroshi ^a,b,g  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR SOX4;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CELL TRANSDIFFERENTIATION; FIBROBLAST; FOX3+ T LYMPHOCYTE; IMMUNIZATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIUM; T LYMPHOCYTE; TH17 CELL;

MUS;

ADOPTIVE TRANSFER; ANIMALS; ARTHRITIS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCK-IN TECHNIQUES; HUMANS; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SYNOVIAL MEMBRANE; TH17 CELLS;

EID: 84891838421     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3432     Document Type: Article

References (42)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
2. Hori, S., Nomura, T. &Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
3. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
4. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
5. Wan, Y.Y. &Flavell, R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770 (2007).
6. Kim, J.M., Rasmussen, J.P. &Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
7. Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 (2009).
8. Yang, X.O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56 (2008).
9. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772-786 (2009).
10. Rubtsov, Y.P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667-1671 (2010).
11. + T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262-275 (2012).
12. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106, 1903-1908 (2009).
13. Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803-2812 (2007).
14. Murakami, M. et al. Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J. Exp. Med. 208, 103-114 (2011).
15. Korn, T., Bettelli, E., Oukka, M. &Kuchroo, V.K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009).
16. Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304 (2007).
17. Hashimoto, M. et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 207, 1135-1143 (2010).
18. Wu, H.J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
19. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001).
20. Sakaguchi, S. et al. The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13, 461-467 (2013).
21. Wehrens, E.J., Prakken, B.J. &van Wijk, F. T cells out of control-impaired immune regulation in the inflamed joint. Nat. Rev. Rheumatol. 9, 34-42 (2013).
22. Ohkura, N. et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37, 785-799 (2012).
23. Feuerer, M. et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. USA 107, 5919-5924 (2010).
24. Zaiss, M.M. et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56, 4104-4112 (2007).
25. Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673-2682 (2006).
26. H17 cells in the absence of TGF-β signalling. Nature 467, 967-971 (2010).
27. H17 cells. Nat. Immunol. 13, 991-999 (2012).
28. H17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513-517 (2013).
29. H17 cells. Nature 496, 518-522 (2013).
30. Malhotra, N. et al. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38, 681-693 (2013).
31. Ramezani-Rad, P. et al. SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood 121, 148-155 (2013).
32. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
33. Sakaguchi, S., Powrie, F. &Ransohoff, R.M. Re-establishing immunological self-tolerance in autoimmune disease. Nat. Med. 18, 54-58 (2012).
34. Yang, X.P. et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12, 247-254 (2011).
35. Tang, Q. et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687-697 (2008).
36. Samson, M. et al. Inhibition of IL-6 function corrects Th17/Treg imbalance in rheumatoid arthritis patients. Arthritis Rheum. 64, 2499-2503 (2012).
37. Nadkarni, S., Mauri, C. &Ehrenstein, M.R. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204, 33-39 (2007).
38. Nie, H. et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat. Med. 19, 322-328 (2013).
39. Viatte, S. et al. Genetics and epigenetics of rheumatoid arthritis. Nat. Rev. Rheumatol. 9, 141-153 (2013).
40. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002).
41. Nakashima, T. et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234 (2011).
42. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002).